In treated patients and in controls six samples were used for each index.

He offered his services and treated patients free of charge.

Total mortality in treated patients (ingestion and wound) is around 33%.

Attacks ceased in 44 of 47 treated patients in one study.

At the end of two weeks, the treated patients had significantly higher bilirubin levels than before treatment.

The treated patients also showed fewer depressive symptoms than before.

Prognosis is very poor, with only 37% of treated patients surviving one year or more.

But in clinical trials, 40% to 50% of treated patients reported that their pain was at least 30% less severe.

But they did not say what percentage of treated patients experienced a 75 percent drop in the disease severity index.

About 12 percent of treated patients showed an improvement in vision of two lines or more.